Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule
or Standard.
On January 11, 2023, Medicus Sciences Acquisition Corp. ("Medicus" or the
"Company"), received a notice (the "Notice") of failure to satisfy a continued
listing standard from Nasdaq under Listing Rules 5620 (a) and 5810(c)(2)(G). The
Notice indicated that the Company failed to hold an annual meeting of
shareholders within the required twelve-month period for the fiscal year ended
December 31, 2022. Under the Listing Rules, the Company has 45 calendar days to
submit a plan to regain compliance. If that plan is accepted, Medicus may be
granted up to 180 calendar days from the fiscal year end, or until June 29,
2023, to regain compliance. Failure to regain compliance with standards for
continued listing would result in the ultimate de-listing of the Company's Class
A ordinary shares, ticker symbol "MSAC", from Nasdaq. Because it is unlikely
Medicus will be able to complete a business combination before its completion
deadline of February 18, 2023, the Company intends to liquidate promptly after
the deadline and therefore will not submit a plan of compliance.
© Edgar Online, source Glimpses
MEDICUS SCIENCES ACQUISITION CORP. 
